Tempus Next Information Center
Get comprehensive updates, key reports, and detailed insights compiled from verified editorial sources.
About to Tempus Next
Jay Baum, PhD and Vice President & Head of Translational Medicine at Lead Therapies joins our own Adam Koch, PhD and ... When Eric Lefkofsky's wife was diagnosed with breast cancer, it exposed how little technology and data were shaping cancer care ... In this insightful episode of FYI, Eric Lefkofsky, CEO of to the podcast on your chosen streaming service: Eric Lefkofsky, CEO and founder of ... Key innovations include Tempus Platform and Tempus One for predictive insights, AI-enabled molecular profiling, Each patient should get the specialized treatment that they deserve.
xM is a portfolio of tumor-naive and tumor-informed minimal residual disease (MRD) and monitoring assays. Learn more at ... ... clinical and molecular data to pharmaceutical companies and optimize clinical trial matching using their
Core Information
Explore the primary sources for Tempus Next.
Developments
Stay updated on Tempus Next's newest achievements.
Featured Video Reports & Highlights
Below is a handpicked selection of video coverage, expert reports, and highlights regarding Tempus Next from verified contributors.
Tempus Next
Tempus | The Next Era of Precision Medicine
The Tempus Data Advantage
Discover Novel Targets & Applications With Tempus Explore | Tempus Webinar
Deep Dive
Data is compiled from public records and verified media reports.
Last Updated: May 24, 2026
Conclusion
For 2026, Tempus Next remains one of the most talked-about profiles. Check back for the newest reports.
Disclaimer:
